Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Financials | 7.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Communication Services | 5.05% |
| 5 | Healthcare | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KMTS
3701
Kestra Medical Technologies
KMTS
$1.63B
| $488K | ﹤0.01% |
29,459
+21,459
| +268% | +$468K |
|
3702
Under Armour Class C
UA
$2.25B
| $487K | ﹤0.01% |
74,980
-3,882
| -5% | -$22.9K |
|
3703
Citizens & Northern Corp
CZNC
$466M
| $486K | ﹤0.01% |
25,663
+9,777
| +62% | +$185K |
|
3704
West Bancorporation
WTBA
$511M
| $486K | ﹤0.01% |
24,736
+8,574
| +53% | +$166K |
|
3705
CALL
PTC Therapeutics
PTCT
$6.01B
| $484K | ﹤0.01% |
+9,900
| New | +$470K |
|
|
OS
3706
DELISTED
OneStream Inc
OS
| $483K | ﹤0.01% |
17,067
-5,764
| -25% | -$144K |
|
3707
TORM
TRMD
$3.01B
| $482K | ﹤0.01% |
28,957
-325,793
| -92% | -$5.45M |
|
3708
Savers
SVV
$1.67B
| $482K | ﹤0.01% |
47,295
+15,511
| +49% | +$152K |
|
|
EB
3709
DELISTED
Eventbrite
EB
| $481K | ﹤0.01% |
182,961
+38,926
| +27% | +$89.7K |
|
3710
NewtekOne
NEWT
$378M
| $480K | ﹤0.01% |
42,539
+15,847
| +59% | +$169K |
|
3711
Tonix Pharmaceuticals
TNXP
$214M
| $478K | ﹤0.01% |
+13,299
| New | +$348K |
|
3712
OraSure Technologies
OSUR
$277M
| $476K | ﹤0.01% |
158,530
+51,572
| +48% | +$149K |
|
3713
MainStreet Bancshares
MNSB
$179M
| $475K | ﹤0.01% |
25,155
+11,251
| +81% | +$205K |
|
3714
Accuray
ARAY
$32.9M
| $474K | ﹤0.01% |
346,267
+152,876
| +79% | +$226K |
|
3715
SharkNinja
SN
$26.6B
| $473K | ﹤0.01% |
4,778
+4,242
| +791% | +$367K |
|
3716
CALL
MoonLake Immunotherapeutics
MLTX
$1.4B
| $472K | ﹤0.01% |
+10,000
| New | +$407K |
|
3717
Amplify Cybersecurity ETF
HACK
$3.08B
| $471K | ﹤0.01% |
5,456
| – | – |
|
3718
Tactile Systems Technology
TCMD
$537M
| $469K | ﹤0.01% |
46,220
-13,593
| -23% | -$155K |
|
3719
Quantum-Si Incorporated
QSI
$172M
| $468K | ﹤0.01% |
239,001
+118,113
| +98% | +$175K |
|
3720
RBB Bancorp
RBB
$466M
| $468K | ﹤0.01% |
27,206
+10,909
| +67% | +$178K |
|
|
FBLA
3721
FB Bancorp
FBLA
$252M
| $468K | ﹤0.01% |
41,617
+13,617
| +49% | +$150K |
|
3722
Lexeo Therapeutics
LXEO
$407M
| $467K | ﹤0.01% |
116,142
+69,475
| +149% | +$228K |
|
3723
Park Aerospace
PKE
$811M
| $467K | ﹤0.01% |
31,589
+12,532
| +66% | +$170K |
|
|
API
3724
Agora
API
$408M
| $466K | ﹤0.01% |
122,236
+2,750
| +2% | +$9.58K |
|
3725
Nkarta
NKTX
$165M
| $465K | ﹤0.01% |
280,312
+33,449
| +14% | +$61.3K |
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.